- MG patients face higher risk of brain inflammation
- Could help explain confusion, memory issues in some
- Not a new treatment — but changes how we treat
This review reveals that myasthenia gravis is often linked to brain inflammation — and that may change how doctors treat tough cases.
You wake up tired, your eyelids droop, and your muscles feel weak. That’s normal for someone with myasthenia gravis (MG). But then, one day, you start forgetting words. You feel confused. You can’t focus.
Doctors might have brushed it off as stress. But what if it’s not? What if the disease attacking your muscles is also attacking your brain?
MG affects about 20 out of every 100,000 people. It weakens the signals between nerves and muscles. People with MG may struggle to speak, swallow, or even breathe.
Most treatments focus on the body — not the brain. But some patients have symptoms that don’t add up. Memory lapses. Hallucinations. Seizures.
Now, experts say these could be signs of something more: autoimmune encephalitis. That’s when the immune system attacks the brain.
And it may be more common in MG patients than we thought.
The Hidden Connection
For years, doctors saw MG and brain inflammation as separate problems. If a patient had both, they assumed it was just bad luck.
But this new review says: it’s not random.
MG and autoimmune encephalitis are both caused by rogue antibodies — the immune system’s attack tools gone wrong.
In MG, those antibodies attack the nerve-muscle connection. It’s like cutting the wires between a switch and a light.
But here’s the twist: some of those same faulty antibodies may also target the brain.
Two Attacks, One Immune System
Think of your immune system like a security team. Normally, it protects you. But in autoimmune diseases, it starts attacking your own cells.
In MG, it attacks the “lock” where nerves tell muscles to move.
In autoimmune encephalitis, it attacks the brain’s “traffic signals” — the parts that help brain cells talk to each other.
Some patients have antibodies that can target both.
It’s like a faulty key that fits two locks — one in the muscle, one in the brain.
What They Didn’t Expect
The review looked at past cases and studies. It found that people with MG are more likely to develop autoimmune encephalitis than the general population.
And it’s not just one type of antibody. Some patients had anti-AChR antibodies (common in MG). Others had anti-LGI1, anti-CASPR2, or anti-NMDAR — usually linked to brain inflammation.
Some even had both at once.
Surprising Symptoms Explained
One patient had classic MG: drooping eyes, weak limbs. Then, suddenly, he started having memory blackouts.
Another woman with MG began hallucinating and became aggressive. Brain scans showed inflammation.
Once doctors treated the brain inflammation, her mind cleared — but her muscle weakness stayed.
This means: treating only the muscles may not be enough.
This doesn’t mean this treatment is available yet.
But There’s a Catch
Not every MG patient will get brain inflammation.
And not every strange mental symptom means encephalitis.
But doctors now need to watch for red flags:
- Sudden confusion
- Memory loss
- Seizures
- Personality changes
These could mean the immune attack has spread to the brain.
How Doctors Should Respond
The review says: treat both conditions early and aggressively.
For MG, standard care includes steroids, IVIg (infused antibodies), or plasma exchange (cleaning the blood).
For autoimmune encephalitis, the same tools are used — plus drugs like rituximab, which resets part of the immune system.
Newer drugs, like FcRn blockers (which help remove harmful antibodies), may help both conditions.
The key is: treat the whole patient — not just the muscles.
Why This Changes Things
We used to think MG only affected the body.
Now, we see it may be part of a broader immune problem.
This could explain why some patients don’t improve with standard MG treatment.
Their brain may be under attack too.
If you or a loved one has MG and new mental symptoms, speak up.
Tell your doctor if you’re confused, forgetful, or acting differently.
Ask: “Could this be more than MG?”
It’s not about scaring you — it’s about getting the right care.
Not All Cases Are the Same
The review is based on case reports and small studies.
It doesn’t prove that all MG patients need brain scans.
And not every mental symptom means encephalitis.
But it does show a clear pattern that doctors can no longer ignore.
More research is needed to find out how often this happens — and who’s most at risk.
Doctors may soon test MG patients for brain-targeting antibodies, even without symptoms.
For now, the message is clear: when MG acts strange, look beyond the muscles.